HEADER METAL BINDING PROTEIN 26-MAR-22 7UHA TITLE NMR STRUCTURE OF THE CNTNC-CTNI CHIMERA BOUND TO W6 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES,TROPONIN I, COMPND 3 CARDIAC MUSCLE; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: TN-C,CARDIAC TROPONIN I; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TNNC1, TNNC, TNNI3, TNNC1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS CARDIAC TROPONIN, CALCIUM BINDING PROTEIN, EF HAND, METAL BINDING KEYWDS 2 PROTEIN, CALCIUM MODULATOR EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR F.CAI,T.KAMPOURAKIS,K.T.COCKBURN,B.D.SYKES REVDAT 3 14-JUN-23 7UHA 1 REMARK REVDAT 2 29-JUN-22 7UHA 1 JRNL REVDAT 1 15-JUN-22 7UHA 0 JRNL AUTH F.CAI,T.KAMPOURAKIS,K.T.COCKBURN,B.D.SYKES JRNL TITL DRUGGING THE SARCOMERE, A DELICATE BALANCE: POSITION OF JRNL TITL 2 N-TERMINAL CHARGE OF THE INHIBITOR W7. JRNL REF ACS CHEM.BIOL. V. 17 1495 2022 JRNL REFN ESSN 1554-8937 JRNL PMID 35649123 JRNL DOI 10.1021/ACSCHEMBIO.2C00126 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7UHA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-MAR-22. REMARK 100 THE DEPOSITION ID IS D_1000264190. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 6.7 REMARK 210 IONIC STRENGTH : NA REMARK 210 PRESSURE : AMBIENT PA REMARK 210 SAMPLE CONTENTS : 0.4 MM [U-100% 13C; U-100% 15N] REMARK 210 CCHIMERA_PROTEIN, 100 MM REMARK 210 POTASSIUM CHLORIDE, 10 MM REMARK 210 IMIDAZOLE, 10 MM CALCIUM REMARK 210 CHLORIDE, 0.25 MM [U-99% 2H] DSS, REMARK 210 2.5 MM W6, 5 % [U-99% 2H] DMSO, REMARK 210 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-13C HSQC; 3D 13C REMARK 210 -FILTERED/EDITED NOESY-HSQC; 2D REMARK 210 13C,15N-DOUBLE-FILTERED TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : VNMRJ, NMRPIPE, NMRVIEWJ, X-PLOR REMARK 210 NIH REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O VAL A 79 H ARG A 83 1.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR A 13 -179.56 -67.87 REMARK 500 1 LYS A 90 -68.56 -129.37 REMARK 500 1 PHE A 138 -80.45 72.69 REMARK 500 1 LYS A 139 95.70 51.81 REMARK 500 1 THR A 142 -7.56 84.20 REMARK 500 1 LEU A 143 161.46 73.64 REMARK 500 1 VAL A 146 86.24 63.63 REMARK 500 1 ALA A 160 25.10 88.99 REMARK 500 1 ALA A 162 -68.18 87.79 REMARK 500 1 LYS A 163 79.85 -66.94 REMARK 500 1 HIS A 165 167.63 67.45 REMARK 500 2 THR A 13 -179.56 -66.85 REMARK 500 2 SER A 37 -167.21 -124.91 REMARK 500 2 ASP A 87 66.56 62.62 REMARK 500 2 LYS A 90 -38.52 70.68 REMARK 500 2 LYS A 137 99.97 -60.23 REMARK 500 2 PHE A 138 52.53 21.83 REMARK 500 2 ARG A 140 170.79 -56.07 REMARK 500 2 LEU A 143 -81.60 49.80 REMARK 500 2 ARG A 145 -77.69 -34.10 REMARK 500 2 ALA A 160 99.19 -162.77 REMARK 500 2 ARG A 161 -168.26 37.11 REMARK 500 2 ALA A 162 63.49 39.31 REMARK 500 3 PRO A 141 -160.03 -63.53 REMARK 500 3 THR A 142 -178.63 90.48 REMARK 500 3 ARG A 144 170.06 69.11 REMARK 500 3 ARG A 145 -81.95 64.37 REMARK 500 3 VAL A 146 -30.51 78.08 REMARK 500 3 ARG A 147 16.79 45.10 REMARK 500 3 HIS A 167 44.27 34.73 REMARK 500 4 ASP A 87 94.12 -64.51 REMARK 500 4 LYS A 90 -125.79 39.93 REMARK 500 4 PHE A 138 155.25 -38.91 REMARK 500 4 LYS A 139 -139.92 -106.42 REMARK 500 4 LEU A 143 -67.37 -175.59 REMARK 500 4 ARG A 144 -157.21 -103.45 REMARK 500 4 ARG A 145 76.14 72.35 REMARK 500 4 ALA A 160 79.43 -64.64 REMARK 500 4 ARG A 161 174.23 62.92 REMARK 500 4 HIS A 165 6.29 -161.75 REMARK 500 4 HIS A 166 103.28 64.03 REMARK 500 5 THR A 13 -179.42 -62.05 REMARK 500 5 LEU A 29 105.00 -55.67 REMARK 500 5 ASP A 87 81.70 22.24 REMARK 500 5 LYS A 90 -115.85 40.73 REMARK 500 5 ARG A 140 169.57 47.46 REMARK 500 5 THR A 142 -178.17 -178.15 REMARK 500 5 ARG A 144 82.50 -15.04 REMARK 500 5 ARG A 145 71.81 14.90 REMARK 500 5 ALA A 160 92.61 62.65 REMARK 500 REMARK 500 THIS ENTRY HAS 89 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 200 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 65 OD1 REMARK 620 2 ASP A 67 OD1 47.9 REMARK 620 3 ASP A 67 OD2 92.5 44.7 REMARK 620 4 SER A 69 OG 98.1 96.7 94.7 REMARK 620 5 THR A 71 O 77.9 125.7 170.4 87.0 REMARK 620 6 GLU A 76 OE1 55.5 87.4 115.7 138.5 58.5 REMARK 620 7 GLU A 76 OE2 106.2 125.3 117.8 137.6 65.5 50.7 REMARK 620 N 1 2 3 4 5 6 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7UH9 RELATED DB: PDB REMARK 900 SAME CITATION REMARK 900 RELATED ID: 31006 RELATED DB: BMRB REMARK 900 NMR STRUCTURE OF THE CNTNC-CTNI CHIMERA BOUND TO W6 DBREF 7UHA A 1 137 UNP P63316 TNNC1_HUMAN 1 92 DBREF 7UHA A 138 163 UNP P19429 TNNI3_HUMAN 139 164 SEQADV 7UHA SER A 35 UNP P63316 CYS 35 ENGINEERED MUTATION SEQADV 7UHA SER A 84 UNP P63316 CYS 84 ENGINEERED MUTATION SEQADV 7UHA GLY A 164 UNP P19429 EXPRESSION TAG SEQADV 7UHA HIS A 165 UNP P19429 EXPRESSION TAG SEQADV 7UHA HIS A 166 UNP P19429 EXPRESSION TAG SEQADV 7UHA HIS A 167 UNP P19429 EXPRESSION TAG SEQADV 7UHA HIS A 168 UNP P19429 EXPRESSION TAG SEQADV 7UHA HIS A 169 UNP P19429 EXPRESSION TAG SEQADV 7UHA HIS A 170 UNP P19429 EXPRESSION TAG SEQRES 1 A 125 MET ASP ASP ILE TYR LYS ALA ALA VAL GLU GLN LEU THR SEQRES 2 A 125 GLU GLU GLN LYS ASN GLU PHE LYS ALA ALA PHE ASP ILE SEQRES 3 A 125 PHE VAL LEU GLY ALA GLU ASP GLY SER ILE SER THR LYS SEQRES 4 A 125 GLU LEU GLY LYS VAL MET ARG MET LEU GLY GLN ASN PRO SEQRES 5 A 125 THR PRO GLU GLU LEU GLN GLU MET ILE ASP GLU VAL ASP SEQRES 6 A 125 GLU ASP GLY SER GLY THR VAL ASP PHE ASP GLU PHE LEU SEQRES 7 A 125 VAL MET MET VAL ARG SER MET LYS ASP ASP SER LYS GLY SEQRES 8 A 125 LYS PHE LYS ARG PRO THR LEU ARG ARG VAL ARG ILE SER SEQRES 9 A 125 ALA ASP ALA MET MET GLN ALA LEU LEU GLY ALA ARG ALA SEQRES 10 A 125 LYS GLY HIS HIS HIS HIS HIS HIS HET CA A 200 1 HET WW6 A 201 41 HETNAM CA CALCIUM ION HETNAM WW6 N-(5-AMINOPENTYL)-5-CHLORONAPHTHALENE-1-SULFONAMIDE FORMUL 2 CA CA 2+ FORMUL 3 WW6 C15 H19 CL N2 O2 S HELIX 1 AA1 ASP A 2 GLN A 11 1 10 HELIX 2 AA2 THR A 13 VAL A 28 1 16 HELIX 3 AA3 SER A 37 GLY A 49 1 13 HELIX 4 AA4 THR A 53 ASP A 65 1 13 HELIX 5 AA5 ASP A 73 LYS A 90 1 18 HELIX 6 AA6 SER A 149 GLY A 159 1 11 HELIX 7 AA7 HIS A 166 HIS A 170 5 5 LINK OD1 ASP A 65 CA CA A 200 1555 1555 2.45 LINK OD1 ASP A 67 CA CA A 200 1555 1555 2.92 LINK OD2 ASP A 67 CA CA A 200 1555 1555 2.70 LINK OG SER A 69 CA CA A 200 1555 1555 2.93 LINK O THR A 71 CA CA A 200 1555 1555 2.88 LINK OE1 GLU A 76 CA CA A 200 1555 1555 2.73 LINK OE2 GLU A 76 CA CA A 200 1555 1555 2.14 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1